Quipt Home Medical (NASDAQ:QIPT) and Global Cord Blood (NYSE:CO) Head-To-Head Review

Global Cord Blood (NYSE:CO) and Quipt Home Medical (NASDAQ:QIPT) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, analyst recommendations, institutional ownership and dividends.

Profitability

This table compares Global Cord Blood and Quipt Home Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Global Cord Blood	N/A	N/A	N/A
Quipt Home Medical	-2.66%	-6.18%	-2.73%

Volatility & Risk

Global Cord Blood has a beta of 0.16, indicating that its stock price is 84% less volatile than the S&P 500. Comparatively, Quipt Home Medical has a beta of 0.56, indicating that its stock price is 44% less volatile than the S&P 500.

Earnings & Valuation

This table compares Global Cord Blood and Quipt Home Medical”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Global Cord Blood	$1.24 billion	0.10	$79.04 million	$0.64	1.58
Quipt Home Medical	$245.91 million	0.53	-$6.76 million	($0.15)	-20.13

Global Cord Blood has higher revenue and earnings than Quipt Home Medical. Quipt Home Medical is trading at a lower price-to-earnings ratio than Global Cord Blood, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Global Cord Blood and Quipt Home Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Global Cord Blood	0	0	0	0	0.00
Quipt Home Medical	1	0	3	2	3.00

Quipt Home Medical has a consensus price target of $6.25, suggesting a potential upside of 106.95%. Given Quipt Home Medical’s stronger consensus rating and higher probable upside, analysts plainly believe Quipt Home Medical is more favorable than Global Cord Blood.

Institutional and Insider Ownership

42.9% of Quipt Home Medical shares are owned by institutional investors. 0.5% of Global Cord Blood shares are owned by insiders. Comparatively, 4.2% of Quipt Home Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Quipt Home Medical beats Global Cord Blood on 8 of the 15 factors compared between the two stocks.

About Global Cord Blood

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.

About Quipt Home Medical

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.